Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging. (12th December 2022)

• Record Type: Journal Article
• Authors: Xie, Fei; Fu, Lilan; Zhou, Wenlan
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 12(2022)
• Page Start: e758
• Page End: e759
• Publication Date: 2022-12-12
• Subjects: 18F-FDG PET/CT -- 68Ga-FAPI-04 PET/CT -- chromophobe renal cell carcinoma -- restaging; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000004374
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: Chromophobe renal cell carcinoma (RCC) is a rare tumor. We described findings of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT of metastatic chromophobe RCC in a 56-year-old woman. 68 Ga-FAPI-04 PET/CT demonstrated that the metastatic lesions in the liver, left posterior abdominal wall, and the left waist had intense uptake of 68 Ga-FAPI-04, which was higher than that of 18 F-FDG on 18 F-FDG PET/CT. 68 Ga-FAPI-04 PET/CT also delineated the metastatic lesions more clearly than 18 F-FDG PET/CT. This case highlights 68 Ga-FAPI-04 PET/CT may be promising in restaging of chromophobe RCC.